Viridian Therapeutics (NASDAQ:VRDN) PT Raised to $61.00
Viridian Therapeutics (NASDAQ:VRDN – Get Free Report) had its price target increased by equities researchers at BTIG Research from $56.00 to $61.00 in a research report issued on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. BTIG Research’s price objective would suggest a potential upside of 161.47% from the company’s […]
More Stories
BV Financial, Inc. (NASDAQ:BVFL) Short Interest Up 17.1% in October
BV Financial, Inc. (NASDAQ:BVFL – Get Free Report) saw a large growth in short interest in the month of October....
Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Down 8.2% in October
Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW – Get Free Report) was the target of a large decrease in short interest in October....
Short Interest in Casey’s General Stores, Inc. (NASDAQ:CASY) Increases By 17.9%
Casey’s General Stores, Inc. (NASDAQ:CASY – Get Free Report) saw a large growth in short interest in October. As of...
Lanvin Group Holdings Limited (NYSE:LANV) Short Interest Down 20.9% in October
Lanvin Group Holdings Limited (NYSE:LANV – Get Free Report) was the target of a significant decline in short interest in...
Northrim BanCorp, Inc. (NASDAQ:NRIM) Short Interest Down 20.5% in October
Northrim BanCorp, Inc. (NASDAQ:NRIM – Get Free Report) was the recipient of a large drop in short interest in October....
Netlist, Inc. (OTCMKTS:NLST) Short Interest Update
Netlist, Inc. (OTCMKTS:NLST – Get Free Report) was the target of a large drop in short interest during the month...